BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32286474)

  • 1. Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses.
    Jiang Z; Fu L; Xu Y; Hu X; Yang H; Zhang Y; Luo H; Gan S; Tao L; Liang G; Shen X
    Sci Rep; 2020 Apr; 10(1):6427. PubMed ID: 32286474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
    Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
    Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
    Liu P; Su J; Song X; Wang S
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress.
    Chen X; Qian J; Wang L; Li J; Zhao Y; Han J; Khan Z; Chen X; Wang J; Liang G
    Endocrine; 2018 Apr; 60(1):83-94. PubMed ID: 29392616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis
    Gao G; Fu L; Xu Y; Tao L; Guo T; Fang G; Zhang G; Wang S; Qin T; Luo P; Shen X
    Front Pharmacol; 2022; 13():906548. PubMed ID: 35865939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
    Ansari M; Kurian GA
    Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
    You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
    J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation.
    Hao J; Zhou J; Hu S; Zhang P; Wu H; Yang J; Zhao B; Liu H; Lin H; Chi J; Lou D
    Am J Physiol Cell Physiol; 2024 Feb; 326(2):C331-C347. PubMed ID: 38047307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
    Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
    J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway.
    Ma W; Guo W; Shang F; Li Y; Li W; Liu J; Ma C; Teng J
    Oxid Med Cell Longev; 2020; 2020():3732718. PubMed ID: 33062139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnamaldehyde Ameliorates High-Glucose-Induced Oxidative Stress and Cardiomyocyte Injury Through Transient Receptor Potential Ankyrin 1.
    Wang D; Hou J; Yang Y; Zhou P; Liu S; Wan J; Wang P
    J Cardiovasc Pharmacol; 2019 Jul; 74(1):30-37. PubMed ID: 31274840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology-Based Strategy Reveals the Effects of
    Zhang S; Yuan Z; Wu H; Li W; Li L; Huang H
    Biomed Res Int; 2020; 2020():8260703. PubMed ID: 33134388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF‑κB signalling pathway in diabetic cardiomyopathy rats.
    Jin Q; Zhu Q; Wang K; Chen M; Li X
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of ROS and NF-κB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries.
    Zhong P; Wu L; Qian Y; Fang Q; Liang D; Wang J; Zeng C; Wang Y; Liang G
    Biochim Biophys Acta; 2015 Jul; 1852(7):1230-41. PubMed ID: 25736300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol induces nuclear localization of Nrf2 under conditions of oxidative stress in cardiac H9c2 cells.
    Shinjo T; Tanaka T; Okuda H; Kawaguchi AT; Oh-Hashi K; Terada Y; Isonishi A; Morita-Takemura S; Tatsumi K; Kawaguchi M; Wanaka A
    PLoS One; 2018; 13(4):e0196191. PubMed ID: 29689082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.
    Chang X; Lu K; Wang L; Lv M; Fu W
    Biosci Trends; 2018 May; 12(2):149-156. PubMed ID: 29607874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling.
    Gao Y; Liu W; Su X; Li X; Yu F; Zhang N
    Oxid Med Cell Longev; 2022; 2022():3959390. PubMed ID: 35656019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection.
    Dreger H; Westphal K; Weller A; Baumann G; Stangl V; Meiners S; Stangl K
    Cardiovasc Res; 2009 Jul; 83(2):354-61. PubMed ID: 19351736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.